February 21, 2025

FDA Approves First Cerebrotendinous Xanthomatosis Treatment

The FDA has approved Ctexli (chenodiol) as the first treatment for cerebrotendinous xanthomatosis, a rare lipid storage disorder.

Conexiant

February 20, 2025

Study Links Parental Drinking to Offspring Cancer Risk

New research in mice suggests that parental alcohol use before conception may predispose male offspring to increased liver cancer susceptibility through epigenetic changes in mitochondrial function. The study identifies mitochondrial dysfunction and inflammation as key mechanisms, with dual-parental exposure producing the most severe effects.

Conexiant

February 19, 2025

GALAD Score Enhances HCC Surveillance Accuracy

GALAD score improves hepatocellular carcinoma detection within 12 months of diagnosis, outperforming AFP in sensitivity and specificity, study shows.

Conexiant

February 18, 2025

AAP Guide Targets Early Biliary Atresia

New AAP clinical report outlines a three-step screening strategy for primary care providers to identify biliary atresia in infants by 2-4 weeks of life, potentially reducing the need for liver transplants.

Conexiant

February 17, 2025

Broccoli Sprout Extract in Prediabetes: Microbiota and Glycemic Variability

Researchers examined the effects of broccoli sprout extract on fasting glucose in prediabetes and observed variability in glycemic response potentially linked to microbiota composition.

Conexiant

February 11, 2025

H pylori: A Hidden Cancer Risk?

Microbial infections like H. pylori drive inflammation, oxidative DNA damage, and immune suppression, fueling cancer initiation and progression.

Conexiant

February 11, 2025

Can Gut Bacteria Predict Your Heart Health?

Study of 21,561 individuals reveals distinct gut microbiome patterns between vegans, vegetarians, and omnivores, with vegan-associated microbes linked to better cardiometabolic health markers.

Conexiant

February 10, 2025

Simvastatin Plus Rifaximin in Cirrhosis: Trial Results

Researchers investigated the impact of simvastatin and rifaximin on liver failure progression in decompensated cirrhosis.

Conexiant

February 10, 2025

Guideline-Based Mental Health Treatment Gaps Identified

Researchers found significant gaps in mental health and substance use disorder treatment.

Conexiant